SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Monday reported first-quarter profit of $150 million.
The San Diego-based company said it had profit of $1.22 per share. Earnings, adjusted for one-time gains and costs, came to $1.60 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.54 per share.
The biopharmaceutical company posted revenue of $376.7 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $357.7 million.
Halozyme Therapeutics expects full-year earnings in the range of $7.75 to $8.25 per share, with revenue in the range of $1.71 billion to $1.81 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO
/AI%20(artificial%20intelligence)/Hands%20of%20robot%20and%20human%20touching%20on%20big%20data%20network%20connection%20by%20PopTika%20via%20Shutterstock.jpg)
/CPU%20Chip.jpg)
